Logo image of SYP.DE

SYNOPSYS INC (SYP.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SYP - US8716071076 - Common Stock

450 EUR
+10.05 (+2.28%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, SYP scores 4 out of 10 in our fundamental rating. SYP was compared to 125 industry peers in the Software industry. There are concerns on the financial health of SYP while its profitability can be described as average. SYP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SYP was profitable.
SYP had a positive operating cash flow in the past year.
In the past 5 years SYP has always been profitable.
Each year in the past 5 years SYP had a positive operating cash flow.
SYP.DE Yearly Net Income VS EBIT VS OCF VS FCFSYP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B -15B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.76%, SYP is in line with its industry, outperforming 46.55% of the companies in the same industry.
SYP's Return On Equity of 4.70% is in line compared to the rest of the industry. SYP outperforms 47.41% of its industry peers.
SYP has a Return On Invested Capital (1.45%) which is comparable to the rest of the industry.
SYP had an Average Return On Invested Capital over the past 3 years of 7.77%. This is significantly below the industry average of 12.89%.
The last Return On Invested Capital (1.45%) for SYP is well below the 3 year average (7.77%), which needs to be investigated, but indicates that SYP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.76%
ROE 4.7%
ROIC 1.45%
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
SYP.DE Yearly ROA, ROE, ROICSYP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

With a decent Profit Margin value of 18.89%, SYP is doing good in the industry, outperforming 75.00% of the companies in the same industry.
SYP's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 12.97%, SYP is in the better half of the industry, outperforming 64.66% of the companies in the same industry.
SYP's Operating Margin has declined in the last couple of years.
SYP's Gross Margin of 76.98% is in line compared to the rest of the industry. SYP outperforms 59.48% of its industry peers.
In the last couple of years the Gross Margin of SYP has remained more or less at the same level.
Industry RankSector Rank
OM 12.97%
PM (TTM) 18.89%
GM 76.98%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
SYP.DE Yearly Profit, Operating, Gross MarginsSYP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SYP is destroying value.
SYP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SYP has been increased compared to 5 years ago.
The debt/assets ratio for SYP is higher compared to a year ago.
SYP.DE Yearly Shares OutstandingSYP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SYP.DE Yearly Total Debt VS Total AssetsSYP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.58 indicates that SYP is not in any danger for bankruptcy at the moment.
The Altman-Z score of SYP (3.58) is comparable to the rest of the industry.
SYP has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
SYP has a Debt to Equity ratio of 0.48. This is in the lower half of the industry: SYP underperforms 62.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 3.58
ROIC/WACC0.13
WACC10.96%
SYP.DE Yearly LT Debt VS Equity VS FCFSYP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

2.3 Liquidity

SYP has a Current Ratio of 1.62. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.62, SYP perfoms like the industry average, outperforming 57.76% of the companies in the same industry.
SYP has a Quick Ratio of 1.52. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.52, SYP is in line with its industry, outperforming 56.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.52
SYP.DE Yearly Current Assets VS Current LiabilitesSYP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. Growth

3.1 Past

SYP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.67%.
The Earnings Per Share has been growing by 18.54% on average over the past years. This is quite good.
The Revenue has grown by 15.12% in the past year. This is quite good.
The Revenue has been growing by 13.87% on average over the past years. This is quite good.
EPS 1Y (TTM)-1.67%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%-14.71%
Revenue 1Y (TTM)15.12%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%37.83%

3.2 Future

The Earnings Per Share is expected to grow by 14.48% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.79% on average over the next years. This is quite good.
EPS Next Y12.9%
EPS Next 2Y15.44%
EPS Next 3Y16.32%
EPS Next 5Y14.48%
Revenue Next Year36.7%
Revenue Next 2Y23.08%
Revenue Next 3Y19.01%
Revenue Next 5Y15.79%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYP.DE Yearly Revenue VS EstimatesSYP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SYP.DE Yearly EPS VS EstimatesSYP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 40.32, which means the current valuation is very expensive for SYP.
The rest of the industry has a similar Price/Earnings ratio as SYP.
SYP is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
SYP is valuated quite expensively with a Price/Forward Earnings ratio of 35.72.
The rest of the industry has a similar Price/Forward Earnings ratio as SYP.
SYP's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.92.
Industry RankSector Rank
PE 40.32
Fwd PE 35.72
SYP.DE Price Earnings VS Forward Price EarningsSYP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYP is valued a bit more expensive than 65.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 70.01
SYP.DE Per share dataSYP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYP does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SYP's earnings are expected to grow with 16.32% in the coming years.
PEG (NY)3.13
PEG (5Y)2.17
EPS Next 2Y15.44%
EPS Next 3Y16.32%

0

5. Dividend

5.1 Amount

SYP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SYNOPSYS INC

FRA:SYP (1/9/2026, 7:00:00 PM)

450

+10.05 (+2.28%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-10 2025-12-10/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners93.54%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap85.76B
Revenue(TTM)7.05B
Net Income(TTM)1.33B
Analysts81.29
Price Target486.13 (8.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.27%
Min EPS beat(2)-10.9%
Max EPS beat(2)2.36%
EPS beat(4)3
Avg EPS beat(4)0.56%
Min EPS beat(4)-10.9%
Max EPS beat(4)6.25%
EPS beat(8)5
Avg EPS beat(8)0.25%
EPS beat(12)9
Avg EPS beat(12)0.93%
EPS beat(16)12
Avg EPS beat(16)1.17%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-2.26%
Revenue beat(12)0
Avg Revenue beat(12)-2.75%
Revenue beat(16)0
Avg Revenue beat(16)-4.52%
PT rev (1m)1.55%
PT rev (3m)-0.14%
EPS NQ rev (1m)7.45%
EPS NQ rev (3m)12.53%
EPS NY rev (1m)1.93%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)0.62%
Revenue NQ rev (3m)0.74%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 40.32
Fwd PE 35.72
P/S 14.15
P/FCF N/A
P/OCF 65.74
P/B 3.52
P/tB N/A
EV/EBITDA 70.01
EPS(TTM)11.16
EY2.48%
EPS(NY)12.6
Fwd EY2.8%
FCF(TTM)-69.11
FCFYN/A
OCF(TTM)6.84
OCFY1.52%
SpS31.8
BVpS127.68
TBVpS-50.71
PEG (NY)3.13
PEG (5Y)2.17
Graham Number179.06
Profitability
Industry RankSector Rank
ROA 2.76%
ROE 4.7%
ROCE 2.06%
ROIC 1.45%
ROICexc 1.55%
ROICexgc 32.83%
OM 12.97%
PM (TTM) 18.89%
GM 76.98%
FCFM N/A
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
ROICexc(3y)10.92%
ROICexc(5y)12.04%
ROICexgc(3y)46.31%
ROICexgc(5y)58.99%
ROCE(3y)11.04%
ROCE(5y)12.54%
ROICexgc growth 3Y-30.11%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-54.14%
ROICexc growth 5Y-30.5%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 8.55
Cap/Depr 2551.48%
Cap/Sales 238.88%
Interest Coverage 2.59
Cash Conversion 96.4%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.52
Altman-Z 3.58
F-Score3
WACC10.96%
ROIC/WACC0.13
Cap/Depr(3y)948.17%
Cap/Depr(5y)656.53%
Cap/Sales(3y)84.22%
Cap/Sales(5y)54.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.67%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%-14.71%
EPS Next Y12.9%
EPS Next 2Y15.44%
EPS Next 3Y16.32%
EPS Next 5Y14.48%
Revenue 1Y (TTM)15.12%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%37.83%
Revenue Next Year36.7%
Revenue Next 2Y23.08%
Revenue Next 3Y19.01%
Revenue Next 5Y15.79%
EBIT growth 1Y-32.51%
EBIT growth 3Y-7.6%
EBIT growth 5Y7.68%
EBIT Next Year84.56%
EBIT Next 3Y32.44%
EBIT Next 5Y15.27%
FCF growth 1Y-1460.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3Y-4.41%
OCF growth 5Y8.9%

SYNOPSYS INC / SYP.DE FAQ

What is the ChartMill fundamental rating of SYNOPSYS INC (SYP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYP.DE.


What is the valuation status for SYP stock?

ChartMill assigns a valuation rating of 1 / 10 to SYNOPSYS INC (SYP.DE). This can be considered as Overvalued.


How profitable is SYNOPSYS INC (SYP.DE) stock?

SYNOPSYS INC (SYP.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SYP stock?

The Price/Earnings (PE) ratio for SYNOPSYS INC (SYP.DE) is 40.32 and the Price/Book (PB) ratio is 3.52.


How financially healthy is SYNOPSYS INC?

The financial health rating of SYNOPSYS INC (SYP.DE) is 4 / 10.